SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-24-047585
Filing Date
2024-05-30
Accepted
2024-05-29 19:38:20
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0206792-f1_nlspharma.htm F-1 199813
2 OPINION OF WENGER VIELI AG, SWISS COUNSEL TO NLS PHARMACEUTICS LTD ea020679201ex5-1_nlspharma.htm EX-5.1 29201
3 CONSENT OF PRICEWATERHOUSECOOPERS AG ea020679201ex23-1_nlspharma.htm EX-23.1 1833
4 FILING FEE TABLE ea020679201ex-fee_nlspharma.htm EX-FILING FEES 14156
5 GRAPHIC image_001.jpg GRAPHIC 8787
6 GRAPHIC ex5-1_001.jpg GRAPHIC 3283
  Complete submission text file 0001213900-24-047585.txt   262915
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-279806 | Film No.: 241000347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)